Bioventus Inc. (BVS)
NASDAQ: BVS · Real-Time Price · USD
8.87
+0.12 (1.37%)
Feb 26, 2026, 12:01 PM EST - Market open
Bioventus Market Cap
Bioventus has a market cap or net worth of $594.08 million as of February 26, 2026. Its market cap has decreased by -15.14% in one year.
Market Cap
594.08M
Enterprise Value
885.05M
1-Year Change
-15.14%
Ranking
Category
Stock Price
$8.87
Market Cap Chart
Since the IPO on February 11, 2021, Bioventus's market cap has decreased from $713.47M to $594.08M, a decrease of -16.73%. That is a compound annual growth rate of -3.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 586.04M | 17.61% |
| Dec 31, 2025 | 498.30M | -27.40% |
| Dec 31, 2024 | 686.36M | 106.84% |
| Dec 29, 2023 | 331.83M | 105.22% |
| Dec 30, 2022 | 161.69M | -81.23% |
| Dec 31, 2021 | 861.26M | 20.71% |
| Feb 11, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SI-BONE | 663.45M |
| Tactile Systems Technology | 642.88M |
| Avanos Medical | 633.15M |
| Perspective Therapeutics | 617.41M |
| Beta Bionics | 593.99M |
| Varex Imaging | 564.65M |
| Cytek Biosciences | 557.49M |
| Orthofix Medical | 504.90M |